What about Fast-track?

FEATUREIs Peer Review Broken?What about Fast-track?Despite a high profile incident, preliminary evidence suggests the practice does not change peer-review quality or rejection ratesBY JOHN DUDLEY MILLER Many biomedical journals offer fast-track peer reviews of scientific articles. Woo-Suk Huang's now- discredited 2005 Science paper about human cloning was accepted 58 days after submission, faster than the

Written byJohn Dudley Miller
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Despite a high profile incident, preliminary evidence suggests the practice does not change peer-review quality or rejection rates

Many biomedical journals offer fast-track peer reviews of scientific articles. Woo-Suk Huang's now- discredited 2005 Science paper about human cloning was accepted 58 days after submission, faster than the journal's 81-day average. Still, it remains unclear what effect, if any, this expedited evaluation has on review quality, rejection rates, or scientific publishing overall.

Some journals define fast-tracking solely as fast reviewing, while others say the term also describes fast publication. The Lancet, British Medical Journal (BMJ), and Journal of Medical Internet Research guarantee publication of successful manuscripts within four weeks of receipt. Other journals, such as The Journal of Interferon & Cytokine Research, guarantee reviews in two weeks but no further speed-up in publication.

Journals also vary in the number of fast-tracked articles they print per year. The Lancet averages between 35 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies